Cultural Tailoring and Pilot Testing of an Inpatient Yoga Therapy Program for Cancer Patients Undergoing Hematopoietic Stem Cell Transplantation in India, Tanzania, and the United States

Launched by M.D. ANDERSON CANCER CENTER · Dec 27, 2022

Keywords

ClinConnect Summary

This clinical trial is exploring a new yoga therapy program designed specifically for cancer patients who are about to undergo a special treatment called hematopoietic stem cell transplantation (HSCT). The goal is to see how this yoga program can help improve the well-being of patients in hospitals in India, Tanzania, and the United States. The program is tailored to fit the cultural backgrounds of the patients, making it more relevant and beneficial for them.

To join this study, participants need to be at least 18 years old and scheduled for HSCT at one of the participating hospitals. They should speak English, Hindi, or Swahili and be able to provide consent to take part in the trial. However, those with severe mobility issues or certain mental health disorders may not be eligible. If you or a loved one joins this trial, you can expect to participate in yoga sessions while in the hospital, which may help with relaxation and recovery during this challenging time.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. Cancer patients scheduled to undergo an autologous or allogeneic HSCT at MD Anderson, HCG, or MNH;
• • 2. Age 18 or older;
• • 3. English, Hindi, or Swahili speaking;
• • 4. Able to sign a written informed consent and be willing to follow protocol requirements.
• Exclusion Criteria:
• • Extreme mobility issues that preclude participating in the YT;
• • Major thought disorders such as schizophrenia or uncontrolled bipolar disorder;
• • HCT comorbidity score of 3 or higher, excluding cancer diagnoses